This selective engagement suggests a distinct metabolic or inflammatory state inherent to these subtypes and indicates that VISFATIN may play a role in unique disease progression pathways or therapeutic resistance mechanisms in T2DM. Here, NAMPT is linked to type 2 diabetes mellitus.